Review highlights impacts of intermittent fasting on metabolic regulation and chronic diseases, suggesting epigenetic modifications play a central role.
Key Points
Intermittent fasting enhances lipid and glucose metabolism, reducing the risk of chronic diseases.
Epigenetic modifications such as DNA methylation impact gene expression related to health outcomes.
Adverse effects may include hormonal imbalances and increased metabolic disease risk, particularly in vulnerable groups.
Personalized dietary recommendations are crucial for optimizing health benefits from intermittent fasting.